Role of Cardiac Magnetic Resonance in Heart Failure with Preserved Ejection Fraction

被引：4
作者：
Pathan F. [1 ,2 ]
Puntmann V.O. [2 ]
Nagel E. [2 ]
机构：
[1] Menzies Institute for Medical Research, University of Tasmania, Hobart
[2] Goethe Institute for Experimental and Translational Cardiovascular Imaging, Goethe CVI, Goethe University Hospital Frankfurt, Theodor-Stern Kai 7, Frankfurt am Main
来源：
Current Cardiovascular Imaging Reports | 2018年 / 11卷 / 5期
关键词：
Aortic pulse wave velocity; Cardiovascular magnetic resonance; Diastolic dysfunction; HFpEF; T1/T2; mapping;
D O I：
10.1007/s12410-018-9450-8
中图分类号：
学科分类号：
摘要：
Purpose of Review: Approximately half of the patients presenting with heart failure have preserved ejection fraction. These patients usually have a combination of underlying etiologies and may profit from individualized treatment. Failure of clinical trials without adequate understanding of the underlying problem highlights the need for an in-depth assessment of this complex clinical syndrome. This review seeks to discuss the role of cardiovascular magnetic resonance imaging (CMR) in improving diagnosis and targeted management of heart failure with preserved ejection fraction (HFpEF). Recent Findings: Technical advances in tissue mapping techniques enable a virtual histopathological perspective to detect myocardial disease processes, such as inflammation, infiltration, and fibrosis. Myocardial perfusion imaging enables separation between regional ischemia due to epicardial coronary artery disease (CAD) and microvascular disease. Finally, computation of aortic pulse wave velocity (PWV) provides insight into the effects of the vascular stiffness on the efficiency of cardiac work. Summary: A comprehensive CMR protocol enables identification of the underlying pathophysiology in patients with HFpEF, allows identification of important differential diagnoses in patients with specific diseases, and may lead to imaging-guided precision medicine in HFpEF. © 2018, Springer Science+Business Media, LLC, part of Springer Nature.
引用
收藏
相关论文
共 98 条
[91]  
Ibrahim el S.H., Johnson K.R., Miller A.B., Shaffer J.M., White R.D., Measuring aortic pulse wave velocity using high-field cardiovascular magnetic resonance: comparison of techniques, J Cardiovasc Magn Reson, 12, 1, (2010)
[92]  
Gori M., Lam C.S., Gupta D.K., Santos A.B., Cheng S., Shah A.M., Et al., Sex-specific cardiovascular structure and function in heart failure with preserved ejection fraction, Eur J Heart Fail, 16, 5, pp. 535-542, (2014)
[93]  
Kawaguchi M., Hay I., Fetics B., Kass D.A., Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction: implications for systolic and diastolic reserve limitations, Circulation, 107, 5, pp. 714-720, (2003)
[94]  
Melenovsky V., Borlaug B.A., Rosen B., Hay I., Ferruci L., Morell C.H., Lakatta E.G., Najjar S.S., Kass D.A., Cardiovascular features of heart failure with preserved ejection fraction versus nonfailing hypertensive left ventricular hypertrophy in the urban Baltimore community: the role of atrial remodeling/dysfunction, J Am Coll Cardiol, 49, 2, pp. 198-207, (2007)
[95]  
Chirinos J.A., Sweitzer N., Ventricular-arterial coupling in chronic heart failure, Card Fail Rev, 3, 1, pp. 12-18, (2017)
[96]  
Nagueh S.F., Smiseth O.A., Appleton C.P., Byrd B.F., Dokainish H., Edvardsen T., Et al., Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging, J Am Soc Echocardiogr, 29, 4, pp. 277-314, (2016)
[97]  
Ather S., Chan W., Bozkurt B., Aguilar D., Ramasubbu K., Zachariah A.A., Wehrens X.H.T., Deswal A., Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction, J Am Coll Cardiol, 59, 11, pp. 998-1005, (2012)
[98]  
Mentz R.J., Kelly J.P., von Lueder T.G., Voors A.A., Lam C.S., Cowie M.R., Et al., Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction, J Am Coll Cardiol, 64, 21, pp. 2281-2293, (2014)
12345678910